jRCT2080222818未知3 期
A phase III parallel group comparison study of HP-3000 in patients with Parkinson's disease using L-DOPA
适应症
试验速览
- 阶段
- 3 期
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Multicenter, randomized, double-blind, parallel group comparison study
入排标准
- 年龄范围
- 20age old over 至 79age old under（—）
- 性别
- All
入选标准
- •Patients diagnosed with Parkinson's disease in stages 2 to 4 on the modified Hoehn & Yahr scale("on" time).
排除标准
- •Patients with a history of hypersensitivity to ropinirole.
- •Patients with clinically significant renal impairment or hepatic dysfunction.
- •Patients who have any cutaneous abnormality at the planned application site that could be aggravated by application of the investigational product.
结局指标
主要结局
-
Efficacy, and safety.
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
A parallel group comparison study of HP-3000 in patients with Parkinson's disease using L-DOPAParkinson's diseaseJPRN-jRCT2080222818Hisamitsu Pharmaceutical Co.,Inc.
未知
3 期
Phase III study of HOB-294 in patients with overactive bladder.Overactive bladderJPRN-jRCT2080221272Hisamitsu Pharmaceutical Co., Inc.
已完成
不适用
Comparative study between parallel groups with placebo for women with daily fatigueJPRN-UMIN000038878Healthcare Systems Co., Ltd.60
尚未招募
1 期
Effect of Marma Chikitsa Agnikarma and Physiotherapy in Avabahuka (Frozen shoulder)CTRI/2023/04/051335Datta Meghe Institute Of Medical science
已完成
不适用
Parallel-group comparative study to evaluate the effect of high-dose nicotinamide mononucleotide (NMN) on agingjRCTs03122037362